You have 9 free searches left this month | for more free features.

Celgene

Showing 51 - 75 of 1,034

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Hodgkin's Lymphoma Trial in Sacramento, Santa Rosa (Rituximab, Lenalidomide)

Active, not recruiting
  • Non Hodgkin's Lymphoma
  • Sacramento, California
  • +1 more
Nov 15, 2021

Myeloma Trial in La Jolla, Orange, Sacramento (Clarithromycin, Dexamethasone, Ixazomib Citrate)

Active, not recruiting
  • Myeloma
  • La Jolla, California
  • +2 more
Mar 14, 2022

Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022

Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 7, 2022

Treatment Outcomes of Esophageal Cancer

Recruiting
  • Esophageal Cancer
  • Assessment of patient-reported outcomes (PROs)
  • Bomet, Kenya
  • +5 more
Dec 15, 2021

CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic

Recruiting
  • Central Nervous System Neoplasm
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 2, 2022

Cord Compression Trial in Saint Louis (Radiation therapy, nab-Paclitaxel)

Terminated
  • Cord Compression
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 15, 2021

Demyelinating Sensorimotor Neuropathy Trial in Ann Arbor, Columbus (Lenalidomide)

Active, not recruiting
  • Demyelinating Sensorimotor Neuropathy
  • Ann Arbor, Michigan
  • +1 more
Nov 3, 2021

Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
Apr 14, 2022

Nummular Eczema, Eczema, Dermatitis Eczema Trial in Munich (Apremilast, Placebo Oral Tablet)

Completed
  • Nummular Eczema
  • +3 more
  • Munich, Bavaria, Germany
    Technical University Munich - Department of Dermatology
Oct 7, 2021

Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

Recruiting
  • Metastatic Non-small Cell Lung Cancer (NSCLC)
  • +5 more
  • data collection
  • Oldenburg, Germany
    Pius-Hospital
Jul 20, 2022

Multiple Myeloma Trial in Tampa (Lenalidomide, Prednisone, Dexamethasone)

Completed
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 8, 2021

Acute Myeloid Leukemia Trial in Chapel Hill (Lenalidomide)

Completed
  • Acute Myeloid Leukemia
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill - Lineberger Compreh
Jan 25, 2022

Itch Trial in Saint Louis (Apremilast)

Completed
  • Itch
  • Saint Louis, Missouri
    Washington University Division of Dermatology
Jun 23, 2021

Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)

Active, not recruiting
  • Prostate Cancer
  • Castration Resistant Prostate Cancer
  • San Francisco, California
  • +4 more
Mar 18, 2022

APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice

Completed
  • Moderate Plaque Psoriasis
    • Athens, Greece
      401 General Military Hospital
    Aug 16, 2021

    Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in United States (Romidepsin, Lenalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Non-Hodgkin's Lymphoma
    • Hartford, Connecticut
    • +6 more
    Jan 3, 2023

    Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

    Active, not recruiting
    • Pancreatic Cancer
    • +2 more
    • Nab-paclitaxel and gemcitabine for R-PDAC Patients
    • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
    • Scottsdale, Arizona
    • +3 more
    Mar 8, 2022

    MDS Trial in Germany (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Hamburg, Germany
    • +4 more
    Dec 20, 2021

    Chronic Lymphocytic Leukemia, CLL Trial in La Jolla (Revlimid, Rituximab)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • CLL
    • La Jolla, California
      University of California, San Diego
    Sep 2, 2021

    Multiple Myeloma Trial in Baltimore (biological, drug, other)

    Recruiting
    • Multiple Myeloma
    • GM-CSF vaccine
    • +4 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Jan 6, 2022

    Chronic Lymphocytic Leukemia Trial in Cologne (lenalidomide, Placebo)

    Completed
    • Chronic Lymphocytic Leukemia
    • Cologne, Germany
    • +1 more
    Dec 16, 2021

    Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

    Recruiting
    • Cutaneous T-cell Lymphoma
    • +4 more
    • Columbus, Ohio
      The Ohio State University Cancer Center
    Apr 18, 2022